Ruminococcaceae

Ruminococcaceae is a major family of obligately anaerobic bacteria within the phylum Bacillota (formerly Firmicutes) and the order Eubacteriales. These bacteria are ubiquitous in the healthy human gut microbiome, where they play a fundamental role in the degradation of complex plant polysaccharides and resistant starch (Louis & Flint, 2017). Through this fermentation process, they produce short-chain fatty acids (SCFAs), notably butyrate, which serves as the primary energy source for intestinal epithelial cells and exhibits potent anti-inflammatory properties (Sokol et al., 2008). A reduction in the abundance of Ruminococcaceae, particularly key genera like Faecalibacterium, is a consistent hallmark of gut dysbiosis associated with inflammatory bowel disease (IBD), obesity, and metabolic syndrome (Guinane & Cotter, 2013). While Ruminococcaceae members are not individual molecular targets such as receptors or enzymes, they are central to microbiome-based therapeutic strategies, including fecal microbiota transplantation (FMT), prebiotics like inulin, and the development of live biotherapeutic products (LBPs) aimed at restoring gut homeostasis (Brito & Alm, 2016). Challenges in targeting these bacteria include their extreme sensitivity to oxygen and the complex ecological interactions within the gut that dictate their colonization and persistence.

Other names

Clostridiales family IVRuminococcus family

Therapeutic interventions aim to modulate the composition and metabolic output of the gut microbiota to restore short-chain fatty acid levels, particularly butyrate, and reduce systemic inflammation.